A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine
Clinical trial NCT00253175 · COMPLETED
Trial details
- NCT number
- NCT00253175
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.